Brief: Dermapharm Holding: FY Consolidated Revenue Up At EUR 942.9 Mln
April 12 (Reuters) - DERMAPHARM HOLDING SE DMPG.DE :
* DIVIDEND PROPOSAL OF EUR 2.17 PER SHARE FOR 2021
* CONSOLIDATED EBITDA FORECASTED TO RISE BY 3-7% IN 2022
* CONSOLIDATED REVENUE EXPECTED TO INCREASE BY 10-13% IN
2022
* FY ADJUSTED CONSOLIDATED EBITDA GROWS BY 74.9% TO EUR
351.1
MILLION
* FY CONSOLIDATED REVENUE RISES 18.8% TO EUR 942.9 MILLION
Source text for Eikon: ID:nEQ6cFRjqa
Further company coverage: DMPG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Dermapharm Holding SE
See all newsBrief: Dermapharm Confirms 2026 Forecast
Corrected: Germany's Dermapharm prelim H1 revenue rises, maintains outlook
Brief: Dermapharm Holding - Confirms Full-Year Guidance For 2026
Brief: Dermapharm Spokesperson - Dermapharm Is Engaged In A Constructive Dialogue With The Regulator
Refile: BUZZ-Dermapharm Holding slips after BaFin's audit